Medtronic CEO Bill Hawkins calls 510(k) reforms a "positive sign"

January 19, 2011 by MassDevice staff

Medtronic Inc. CEO William Hawkins tells MassDevice that he's encouraged by changes to the 510(k) program detailed today by the Food & Drug Administration, but adds that there's more work to be done to eliminate "uncertainty."

MDT, Bill Hawkins

Medtronic Inc. (NYSE:MDT) CEO William "Bill" Hawkins reacted positively to changes the Food & Drug Administration announced today for its 510(k) program, calling them a "positive sign" that regulators are open to working more collaboratively with industry but denying that the medical device industry won a round in the fight against stricter regulation.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.